POZEN Inc. (POZN) Stock Quote

Detailed Quote for POZEN Inc. (POZN) 
$ 4.47   -0.10 (-2.19%) Volume: 10.5 k 10:42 AM EST Feb 10, 2012
Today 5d 1m 3m 1y more
Last Price
4.47
Change $
0.10
Change %
2.19%
Tick
  
Bid
4.48
Bid Size
500
Ask
4.50
Ask Size
100
Open
4.51
High
4.529
Low
4.45
Prev Close
4.57
Last Trade
10:42
Volume
10.5 k
52 Wk Hi
6.39
52 Wk Low
2.15
Market Cap
133.72 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
29,915,347
EPS (TTM)
-0.03
PE Ratio
N/A
Exchange
NSD
News and Media for POZEN Inc.  (POZN) 
Sector News | Topic News
News for POZN
Thu, Feb 02, 2012
7:30 AM POZEN's Digital Advisory Board to Speak at Annual ePharma Summit - Business Wire
Wed, Feb 01, 2012
6:00 PM Preventive Aspirin Use Less Than Optimal in Stroke Survivors Despite Clinical Guidelines - Business Wire
Wed, Jan 11, 2012
7:01 AM Q&A Exclusive: POZEN's Team Confident About Building Shareholder Value in 2012 and Beyond - Marketwire
Mon, Nov 28, 2011
7:30 AM POZEN Monetizes Its Treximet Royalty Stream for $75 Million - Business Wire
Thu, Nov 17, 2011
7:31 AM POZEN to Present at the Piper Jaffray 23rd Annual Healthcare Conference - Business Wire
Mon, Nov 14, 2011
11:30 AM Positive Results from POZEN Phase 1 Study ("Co-Rx") Presented At AHA - Business Wire
More News for POZN >>

Tags for POZEN Inc.

Research stocks or mutual funds related to POZEN Inc. by keywords or tags. Find companies that have a similar focus to POZN. The keywords below have been associated to POZN by either user submission or electronic means.

pharmaceutical sales data pharmaceutical articles biotech research clinical trial enrollment clinical research trial pharmaceutical branding pharmaceutical industry strategy pharmaceutical publication pharmaceutical market generic pharmaceutical pharmaceutical investment pharmaceutical automation niche pharmaceutical pharmaceutical specialties jobs in pharmaceutical pharmaceutical training pharmaceutical patents medical product development pharmaceutical research and development biotech jobs pharmaceutical supplies pharmaceutical manufacturing company pharma marketing pharmaceutical industry marketing migraine treatment corporate governance pharmaceutical tank pharmaceutical software pharma manufacturing pharma license pfizer pharmaceutical company kv pharmaceutical company corporate governance issues pharmaceutical executives clinical research corporate governance ratings pharmaceutical ingredients pharmaceutical cro pharma companies pharma consulting active pharmaceutical ingredients good corporate governance pharmaceutical sales pfizer paid clinical trial pharma fda clinical trial pharmaceutical distributors biotech corporation pharmaceutical development

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.